Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.
Authors: Yang JC; National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan., Lee DH; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea., Lee JS; Seoul National University Bundang Hospital, Seoul, South Korea., Fan Y; Zhejiang Cancer Hospital, Hangzhou, China., de Marinis F; Istituto Europeo di Oncologia, IRCCS, Milan, Italy., Iwama E; Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan., Inoue T; Osaka International Cancer Institute, Osaka, Japan., Rodríguez-Cid J; Oncology Center, Medica Sur Hospital, Mexico City, Mexico., Zhang L; Peking Union Medical College Hospital, Beijing, China., Yang CT; Chang Gung Memorial Hospital, Taoyuan, Taiwan., de la Mora Jimenez E; Instituto Jalisciense de Cancerología, Guadalajara, Mexico., Zhou J; The First Affiliated Hospital, Zhejiang University, Zhejiang, China., Pérol M; Centre Léon Bérard, Lyon, France., Lee KH; Chungbuk National University Hospital, Cheongju-si, South Korea., Vicente D; Hospital Universitario Virgen Macarena, Sevilla, Spain., Ichihara E; Okayama University Hospital, Okayama, Japan., Riely GJ; Memorial Sloan Kettering Cancer Center, New York, NY., Luo Y; Merck & Co, Inc, Rahway, NJ., Chirovsky D; Merck & Co, Inc, Rahway, NJ., Pietanza MC; Merck & Co, Inc, Rahway, NJ., Bhagwati N; Merck & Co, Inc, Rahway, NJ., Lu S; Shanghai Chest Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Dec; Vol. 42 (34), pp. 4029-4039. Date of Electronic Publication: 2024 Aug 22.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO.23.02747